Directed therapies in lung cancer: new hope?
- PMID: 22551924
- DOI: 10.1016/j.arbres.2012.03.007
Directed therapies in lung cancer: new hope?
Abstract
Lung cancer (LC) is a serious health problem due to its high incidence and mortality. Surgery is the most effective therapeutic strategy in this type of tumor, but in recent years new drugs are being investigated that target specific components of the tumor cells, improving survival in patients with advanced disease and relapse. We present a review of individualized treatments in LC, particularly therapies that inhibit epidermal growth factor receptor (EGFR), vascular endothelial growth factor (VEGF) and anaplastic lymphoma kinase (ALK).
Copyright © 2011 SEPAR. Published by Elsevier España, S.L. All rights reserved.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Research Materials